决策模型在IDEAL框架最早阶段的优势:DIEP皮瓣乳房再造中的创新案例
该研究以双侧DIEP皮瓣乳房再造中的一项创新为例,展示在IDEAL框架0-1阶段即可采用决策模型。通过头空间分析、情景分析和阈值分析量化预期成本与质量调整生命年,结果显示若消除全部并发症每位患者最多可节省889欧元,情景分析显示每位患者可节省256至828欧元。
要点
- 在IDEAL框架0-1阶段即可采用决策模型评估外科创新。
- 消除全部并发症时每位患者最多可节省889欧元。
- 三种情景分析显示每位患者可节省256至828欧元。
核心结论
- 决策模型可帮助在早期阶段将有前景的创新与高成本的失败区分开;在本例中,决策模型显示进一步开发该创新似乎值得。
研究设计与样本
- 以双侧DIEP皮瓣乳房再造中的一项创新为例,在IDEAL框架最早阶段(0-1)应用决策模型,量化当前治疗与创新的预期成本和QALY。
主要发现
- 头空间分析显示,当当前治疗相关的全部并发症被预防时,每位患者最多可节省889欧元。
- 情景分析显示每位患者可节省256至828欧元。
- 当手术时间减少15分钟且并发症减少50%时,该创新在每位患者671欧元时仍具有成本效果。
关键数值与推荐
- 头空间分析:消除全部并发症时每位患者最多节省889欧元。
- 情景分析:每位患者节省256至828欧元。
- 手术时间减少15分钟且并发症减少50%时,该创新在每位患者671欧元时仍具有成本效果。
- 阈值分析根据创新的影响和社会支付意愿估计其最高价格。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The IDEAL framework aims at improving the evidence base of available surgical innovations. However, the development of such innovations and collection of evidence is costly. Surgical innovation can provide more value for money if innovations are evaluated at an early stage, where evaluations can inform the decision whether to stop or to further develop an innovation. We illustrate how decision modelling can be readily adopted at the earliest stages (0-1) of the IDEAL framework, using an innovation in bilateral DIEP flap breast reconstruction as an example. METHODS: We quantified expected costs and quality-adjusted life years (QALYs) of the current treatment and compared them with an innovation aimed at reducing complications and surgery time. The maximum effect of eliminating all complications (headroom analysis) was explored. Moreover, three scenarios with varying complications and surgery time reductions were modelled. Furthermore, the maximum price of the innovation was estimated in a threshold analysis according to its impact and societal willingness to pay. RESULTS: The headroom analysis showed that when all complications associated with the current treatment are prevented, up to €889 per patient is saved. Scenario analysis showed cost savings between €256 and €828 per patient. When surgery time is reduced by 15 min and complications by 50%, the innovation will remain cost-effective at €671 per patient. CONCLUSION: In a field struggling with cost containment, decision modelling can help to separate promising innovations from costly failures at an early stage. In this example, decision modelling showed that it seems worthwhile to further develop the innovation.
引用
- Hummelink S, Gerrits JGW, Schultze Kool LJ, et al. The merits of decision modelling in the earliest stages of the IDEAL framework: An innovative case in DIEP flap breast reconstructions. J Plast Reconstr Aesthet Surg. 2017. PMID: 28882494. doi:10.1016/j.bjps.2017.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。